Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

2716

LikeLikedUnlike

Episodes 541-555 of 739

The Role of Biomarker-Driven Therapies in the Second-Line Treatment of Advanced Gastric/GEJ Cancers: What Do the Data Say?
MinuteCE®
The Role of Biomarker-Driven Therapies in the Second-Line Treatment of Advanced Gastric/GEJ Cancers: What Do the Data Say?
- Sara Lonardi, MD
  Peer
1.25 program credits
First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study
MinuteCE®
First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study
- Sara Lonardi, MD
  Peer
1.25 program credits
Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence
MinuteCE®
Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence
- Alan Venook, MD
  Peer
1.25 program credits
First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy
MinuteCE®
First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy
- Aparna R. Parikh, MD
  Peer
1.25 program credits
Current Guideline Recommendations for Biomarker-Based Second-Line Treatment of mCRC
MinuteCE®
Current Guideline Recommendations for Biomarker-Based Second-Line Treatment of mCRC
- Aparna R. Parikh, MD
  Peer
1.25 program credits
Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion
MinuteCE®
Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion
- Aparna R. Parikh, MD
  Peer
1.25 program credits
advertisement
Emerging Directions in Biomarker-Directed Therapy for GI Malignancies
MinuteCE®
Emerging Directions in Biomarker-Directed Therapy for GI Malignancies
- Alan Venook, MD
  Peer
1.25 program credits
Novel Neoadjuvant and Adjuvant Immunotherapy Strategies for GI Malignancies: The Evidence
MinuteCE®
Novel Neoadjuvant and Adjuvant Immunotherapy Strategies for GI Malignancies: The Evidence
- Alan Venook, MD
  Peer
1.25 program credits
Expert Opinion: Key Insights on GI Malignancies—Integrating NCCN Clinical Practice Guidelines Into Practice
MinuteCE®
Expert Opinion: Key Insights on GI Malignancies—Integrating NCCN Clinical Practice Guidelines Into Practice
- Sara Lonardi, MD
  Peer
- Aparna R. Parikh, MD
  Peer
- Alan Venook, MD
  Peer
1.25 program credits
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
CME/CE
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
- Mazen Hanna, MD
  Peer
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
CME/CE
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
- James R. Bateman, MD, MPH
  Peer
- Jerome A. Barakos, MD
  Peer
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
  Peer
- B. Joy Snider, MD, PhD
  Peer
0.50 credits
Cardiorenal Collaboration: Escape the Treatment Trap
CME/CE
Cardiorenal Collaboration: Escape the Treatment Trap
1.00 credits
advertisement
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection
CME/CE
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection
- Mark Socinski, MD
  Peer
0.25 credits
MinuteCE®
Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers
- Ignacio Duran, MD
  Peer
- Wenxin Xu, MD
  Peer
- Sandy Srinivas, MD
  Peer
1.25 credits 10 episodes
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
CME/CE Broadcast Replay
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
- Robert P. Frantz, MD, FACC
  Peer
- Vallerie V. McLaughlin, MD
  Peer
- Sonja Bartolomei, MD
  Peer
1.00 credits

Program Chapters

Segment Chapters

Playlist:

Recommended